The T cells of the immune system can be engineered to target a tumour, but why some people respond better than others to such therapy is unclear. One patient's striking response to treatment now offers some clues.
CITATION STYLE
Maus, M. V. (2018). Tumour tamed by transfer of one T cell news-and-views. Nature, 558(7709), 193–195. https://doi.org/10.1038/d41586-018-05251-5
Mendeley helps you to discover research relevant for your work.